G. ÖZTAN Et Al. , "Determining the Relationship of XPO1 Mutations to the Pathogenesis of CLL," XIII. AZIZ SANCAR INSTITUTE OF EXPERIMENTAL MEDICINE DAYS Omics Technologies in Life Sciences: From Genome to Therapy , vol.12, Turkey, pp.13-15, 2021
ÖZTAN, G. Et Al. 2021. Determining the Relationship of XPO1 Mutations to the Pathogenesis of CLL. XIII. AZIZ SANCAR INSTITUTE OF EXPERIMENTAL MEDICINE DAYS Omics Technologies in Life Sciences: From Genome to Therapy , (Turkey), 13-15.
ÖZTAN, G., OĞUZ, F., & İŞSEVER, H., (2021). Determining the Relationship of XPO1 Mutations to the Pathogenesis of CLL . XIII. AZIZ SANCAR INSTITUTE OF EXPERIMENTAL MEDICINE DAYS Omics Technologies in Life Sciences: From Genome to Therapy (pp.13-15). , Turkey
ÖZTAN, Gözde, Fatma OĞUZ, And Halim İŞSEVER. "Determining the Relationship of XPO1 Mutations to the Pathogenesis of CLL," XIII. AZIZ SANCAR INSTITUTE OF EXPERIMENTAL MEDICINE DAYS Omics Technologies in Life Sciences: From Genome to Therapy, Turkey, 2021
ÖZTAN, Gözde Et Al. "Determining the Relationship of XPO1 Mutations to the Pathogenesis of CLL." XIII. AZIZ SANCAR INSTITUTE OF EXPERIMENTAL MEDICINE DAYS Omics Technologies in Life Sciences: From Genome to Therapy , Turkey, pp.13-15, 2021
ÖZTAN, G. OĞUZ, F. And İŞSEVER, H. (2021) . "Determining the Relationship of XPO1 Mutations to the Pathogenesis of CLL." XIII. AZIZ SANCAR INSTITUTE OF EXPERIMENTAL MEDICINE DAYS Omics Technologies in Life Sciences: From Genome to Therapy , Turkey, pp.13-15.
@conferencepaper{conferencepaper, author={Gözde ÖZTAN Et Al. }, title={Determining the Relationship of XPO1 Mutations to the Pathogenesis of CLL}, congress name={XIII. AZIZ SANCAR INSTITUTE OF EXPERIMENTAL MEDICINE DAYS Omics Technologies in Life Sciences: From Genome to Therapy}, city={}, country={Turkey}, year={2021}, pages={13-15} }